Last 12 months
Inside the activity.
2 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 2 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 23, 2023 Filed Aug 25, 2023 18:27 UTC |
Tavares BernardoChief Tech & Data Officer
|
GrantStock Options · Derivative | 22,543 | $0.00 Strike: $17.82 | $0.00 |
DisclosureSEC source: 0001944048-23-000058 · wk-form4_1693002435.xml · derivative · entry 11 Tavares Bernardo · CIK 0001966908 · Chief Tech & Data Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,543 Underlying: Common Stock · 22,543 shares Expires 2029-02-11 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F8 · derivative.exercise_date: This award is fully vested. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 18:27 UTC |
Tavares BernardoChief Tech & Data Officer
|
GrantStock Options · Derivative | 30,210 | $0.00 Strike: $20.44 | $0.00 |
DisclosureSEC source: 0001944048-23-000058 · wk-form4_1693002435.xml · derivative · entry 10 Tavares Bernardo · CIK 0001966908 · Chief Tech & Data Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,210 Underlying: Common Stock · 30,210 shares Expires 2030-02-10 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F8 · derivative.exercise_date: This award is fully vested. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 18:27 UTC |
Tavares BernardoChief Tech & Data Officer
|
GrantStock Options · Derivative | 26,173 | $0.00 Strike: $22.23 | $0.00 |
DisclosureSEC source: 0001944048-23-000058 · wk-form4_1693002435.xml · derivative · entry 9 Tavares Bernardo · CIK 0001966908 · Chief Tech & Data Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,173 Underlying: Common Stock · 26,173 shares Expires 2031-02-08 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F4 · derivative.exercise_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 18:27 UTC |
Tavares BernardoChief Tech & Data Officer
|
GrantStock Options · Derivative | 26,573 | $0.00 Strike: $22.40 | $0.00 |
DisclosureSEC source: 0001944048-23-000058 · wk-form4_1693002435.xml · derivative · entry 8 Tavares Bernardo · CIK 0001966908 · Chief Tech & Data Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,573 Underlying: Common Stock · 26,573 shares Expires 2032-02-14 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F3 · derivative.exercise_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 18:27 UTC |
Tavares BernardoChief Tech & Data Officer
|
GrantStock Options · Derivative | 33,173 | $0.00 Strike: $21.97 | $0.00 |
DisclosureSEC source: 0001944048-23-000058 · wk-form4_1693002435.xml · derivative · entry 7 Tavares Bernardo · CIK 0001966908 · Chief Tech & Data Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,173 Underlying: Common Stock · 33,173 shares Expires 2033-02-13 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F2 · derivative.exercise_date: This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 18:27 UTC |
Tavares BernardoChief Tech & Data Officer
|
GrantRestricted Stock Units · Derivative | 7,608 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000058 · wk-form4_1693002435.xml · derivative · entry 6 Tavares Bernardo · CIK 0001966908 · Chief Tech & Data Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,608 Underlying: Common Stock · 7,608 shares Expires not disclosed F5 · security: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F5 · derivative.exercise_price: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F4 · derivative.exercise_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. F4 · derivative.expiration_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 18:27 UTC |
Tavares BernardoChief Tech & Data Officer
|
GrantRestricted Stock Units · Derivative | 6,727 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000058 · wk-form4_1693002435.xml · derivative · entry 5 Tavares Bernardo · CIK 0001966908 · Chief Tech & Data Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,727 Underlying: Common Stock · 6,727 shares Expires not disclosed F5 · security: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F5 · derivative.exercise_price: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F3 · derivative.exercise_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. F3 · derivative.expiration_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 18:27 UTC |
Tavares BernardoChief Tech & Data Officer
|
GrantRestricted Stock Units · Derivative | 10,320 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000058 · wk-form4_1693002435.xml · derivative · entry 4 Tavares Bernardo · CIK 0001966908 · Chief Tech & Data Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,320 Underlying: Common Stock · 10,320 shares Expires not disclosed F5 · security: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F5 · derivative.exercise_price: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F6 · derivative.exercise_date: This award will vest in full on 02/13/2026, subject to the reporting person's continued service through the vesting date. F6 · derivative.expiration_date: This award will vest in full on 02/13/2026, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 18:27 UTC |
Tavares BernardoChief Tech & Data Officer
|
GrantRestricted Stock Units · Derivative | 2,385 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000058 · wk-form4_1693002435.xml · derivative · entry 3 Tavares Bernardo · CIK 0001966908 · Chief Tech & Data Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,385 Underlying: Common Stock · 2,385 shares Expires not disclosed F1 · security: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F1 · derivative.exercise_price: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F4 · derivative.exercise_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. F4 · derivative.expiration_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 18:27 UTC |
Tavares BernardoChief Tech & Data Officer
|
GrantRestricted Stock Units · Derivative | 2,689 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000058 · wk-form4_1693002435.xml · derivative · entry 2 Tavares Bernardo · CIK 0001966908 · Chief Tech & Data Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,689 Underlying: Common Stock · 2,689 shares Expires not disclosed F1 · security: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F1 · derivative.exercise_price: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F3 · derivative.exercise_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. F3 · derivative.expiration_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 18:27 UTC |
Tavares BernardoChief Tech & Data Officer
|
GrantRestricted Stock Units · Derivative | 4,008 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000058 · wk-form4_1693002435.xml · derivative · entry 1 Tavares Bernardo · CIK 0001966908 · Chief Tech & Data Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,008 Underlying: Common Stock · 4,008 shares Expires not disclosed F1 · security: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F1 · derivative.exercise_price: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F2 · derivative.exercise_date: This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date. F2 · derivative.expiration_date: This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 18:30 UTC |
Tillett CarolineChief Scientific Officer
|
GrantStock Options · Derivative | 73,348 | $0.00 Strike: $22.23 | $0.00 |
DisclosureSEC source: 0001944048-23-000060 · wk-form4_1693002588.xml · derivative · entry 9 Tillett Caroline · CIK 0001966949 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,348 Underlying: Common Stock · 73,348 shares Expires 2031-02-08 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F4 · derivative.exercise_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 18:30 UTC |
Tillett CarolineChief Scientific Officer
|
GrantStock Options · Derivative | 75,541 | $0.00 Strike: $22.40 | $0.00 |
DisclosureSEC source: 0001944048-23-000060 · wk-form4_1693002588.xml · derivative · entry 8 Tillett Caroline · CIK 0001966949 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,541 Underlying: Common Stock · 75,541 shares Expires 2032-02-14 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F3 · derivative.exercise_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 18:30 UTC |
Tillett CarolineChief Scientific Officer
|
GrantStock Options · Derivative | 74,422 | $0.00 Strike: $21.97 | $0.00 |
DisclosureSEC source: 0001944048-23-000060 · wk-form4_1693002588.xml · derivative · entry 7 Tillett Caroline · CIK 0001966949 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,422 Underlying: Common Stock · 74,422 shares Expires 2033-02-13 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F2 · derivative.exercise_date: This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 18:30 UTC |
Tillett CarolineChief Scientific Officer
|
GrantRestricted Stock Units · Derivative | 21,321 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000060 · wk-form4_1693002588.xml · derivative · entry 6 Tillett Caroline · CIK 0001966949 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,321 Underlying: Common Stock · 21,321 shares Expires not disclosed F5 · security: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F5 · derivative.exercise_price: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F4 · derivative.exercise_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. F4 · derivative.expiration_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 18:30 UTC |
Tillett CarolineChief Scientific Officer
|
GrantRestricted Stock Units · Derivative | 19,121 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000060 · wk-form4_1693002588.xml · derivative · entry 5 Tillett Caroline · CIK 0001966949 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,121 Underlying: Common Stock · 19,121 shares Expires not disclosed F5 · security: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F5 · derivative.exercise_price: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F3 · derivative.exercise_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. F3 · derivative.expiration_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 18:30 UTC |
Tillett CarolineChief Scientific Officer
|
GrantRestricted Stock Units · Derivative | 23,158 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000060 · wk-form4_1693002588.xml · derivative · entry 4 Tillett Caroline · CIK 0001966949 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,158 Underlying: Common Stock · 23,158 shares Expires not disclosed F5 · security: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F5 · derivative.exercise_price: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F6 · derivative.exercise_date: This award will vest in full on 02/13/2026, subject to the reporting person's continued service through the vesting date. F6 · derivative.expiration_date: This award will vest in full on 02/13/2026, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 18:30 UTC |
Tillett CarolineChief Scientific Officer
|
GrantRestricted Stock Units · Derivative | 6,675 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000060 · wk-form4_1693002588.xml · derivative · entry 3 Tillett Caroline · CIK 0001966949 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,675 Underlying: Common Stock · 6,675 shares Expires not disclosed F1 · security: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F1 · derivative.exercise_price: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F4 · derivative.exercise_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. F4 · derivative.expiration_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 18:30 UTC |
Tillett CarolineChief Scientific Officer
|
GrantRestricted Stock Units · Derivative | 7,645 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000060 · wk-form4_1693002588.xml · derivative · entry 2 Tillett Caroline · CIK 0001966949 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,645 Underlying: Common Stock · 7,645 shares Expires not disclosed F1 · security: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F1 · derivative.exercise_price: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F3 · derivative.exercise_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. F3 · derivative.expiration_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 18:30 UTC |
Tillett CarolineChief Scientific Officer
|
GrantRestricted Stock Units · Derivative | 8,994 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000060 · wk-form4_1693002588.xml · derivative · entry 1 Tillett Caroline · CIK 0001966949 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,994 Underlying: Common Stock · 8,994 shares Expires not disclosed F1 · security: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F1 · derivative.exercise_price: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F2 · derivative.exercise_date: This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date. F2 · derivative.expiration_date: This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 18:25 UTC |
Stevens MeredithChief Operations Officer
|
GrantStock Options · Derivative | 103,566 | $0.00 Strike: $22.23 | $0.00 |
DisclosureSEC source: 0001944048-23-000056 · wk-form4_1693002313.xml · derivative · entry 9 Stevens Meredith · CIK 0001967093 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,566 Underlying: Common Stock · 103,566 shares Expires 2031-02-08 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F4 · derivative.exercise_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 18:25 UTC |
Stevens MeredithChief Operations Officer
|
GrantStock Options · Derivative | 96,721 | $0.00 Strike: $22.40 | $0.00 |
DisclosureSEC source: 0001944048-23-000056 · wk-form4_1693002313.xml · derivative · entry 8 Stevens Meredith · CIK 0001967093 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,721 Underlying: Common Stock · 96,721 shares Expires 2032-02-14 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F3 · derivative.exercise_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 18:25 UTC |
Stevens MeredithChief Operations Officer
|
GrantStock Options · Derivative | 79,801 | $0.00 Strike: $21.97 | $0.00 |
DisclosureSEC source: 0001944048-23-000056 · wk-form4_1693002313.xml · derivative · entry 7 Stevens Meredith · CIK 0001967093 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,801 Underlying: Common Stock · 79,801 shares Expires 2033-02-13 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F2 · derivative.exercise_date: This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 18:25 UTC |
Stevens MeredithChief Operations Officer
|
GrantRestricted Stock Units · Derivative | 30,099 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000056 · wk-form4_1693002313.xml · derivative · entry 6 Stevens Meredith · CIK 0001967093 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,099 Underlying: Common Stock · 30,099 shares Expires not disclosed F5 · security: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F5 · derivative.exercise_price: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F4 · derivative.exercise_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. F4 · derivative.expiration_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 18:25 UTC |
Stevens MeredithChief Operations Officer
|
GrantRestricted Stock Units · Derivative | 24,484 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000056 · wk-form4_1693002313.xml · derivative · entry 5 Stevens Meredith · CIK 0001967093 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,484 Underlying: Common Stock · 24,484 shares Expires not disclosed F5 · security: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F5 · derivative.exercise_price: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F3 · derivative.exercise_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. F3 · derivative.expiration_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 18:25 UTC |
Stevens MeredithChief Operations Officer
|
GrantRestricted Stock Units · Derivative | 24,825 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000056 · wk-form4_1693002313.xml · derivative · entry 4 Stevens Meredith · CIK 0001967093 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,825 Underlying: Common Stock · 24,825 shares Expires not disclosed F5 · security: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F5 · derivative.exercise_price: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F6 · derivative.exercise_date: This award will vest in full on 02/13/2026, subject to the reporting person's continued service through the vesting date. F6 · derivative.expiration_date: This award will vest in full on 02/13/2026, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 18:25 UTC |
Stevens MeredithChief Operations Officer
|
GrantRestricted Stock Units · Derivative | 9,431 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000056 · wk-form4_1693002313.xml · derivative · entry 3 Stevens Meredith · CIK 0001967093 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,431 Underlying: Common Stock · 9,431 shares Expires not disclosed F1 · security: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F1 · derivative.exercise_price: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F4 · derivative.exercise_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. F4 · derivative.expiration_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 18:25 UTC |
Stevens MeredithChief Operations Officer
|
GrantRestricted Stock Units · Derivative | 9,794 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000056 · wk-form4_1693002313.xml · derivative · entry 2 Stevens Meredith · CIK 0001967093 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,794 Underlying: Common Stock · 9,794 shares Expires not disclosed F1 · security: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F1 · derivative.exercise_price: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F3 · derivative.exercise_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. F3 · derivative.expiration_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 18:25 UTC |
Stevens MeredithChief Operations Officer
|
GrantRestricted Stock Units · Derivative | 9,645 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000056 · wk-form4_1693002313.xml · derivative · entry 1 Stevens Meredith · CIK 0001967093 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,645 Underlying: Common Stock · 9,645 shares Expires not disclosed F1 · security: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F1 · derivative.exercise_price: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F2 · derivative.exercise_date: This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date. F2 · derivative.expiration_date: This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:38 UTC |
Xie BingGroup President APAC
|
GrantStock Options · Derivative | 42,552 | $0.00 Strike: $15.62 | $0.00 |
DisclosureSEC source: 0001944048-23-000066 · wk-form4_1693003089.xml · derivative · entry 13 Xie Bing · CIK 0001967716 · Group President APAC 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,552 Underlying: Common Stock · 42,552 shares Expires 2027-02-13 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F8 · derivative.exercise_date: This award is fully vested. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:38 UTC |
Xie BingGroup President APAC
|
GrantStock Options · Derivative | 42,263 | $0.00 Strike: $17.49 | $0.00 |
DisclosureSEC source: 0001944048-23-000066 · wk-form4_1693003089.xml · derivative · entry 12 Xie Bing · CIK 0001967716 · Group President APAC 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,263 Underlying: Common Stock · 42,263 shares Expires 2028-02-12 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F8 · derivative.exercise_date: This award is fully vested. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:38 UTC |
Xie BingGroup President APAC
|
GrantStock Options · Derivative | 56,168 | $0.00 Strike: $17.82 | $0.00 |
DisclosureSEC source: 0001944048-23-000066 · wk-form4_1693003089.xml · derivative · entry 11 Xie Bing · CIK 0001967716 · Group President APAC 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,168 Underlying: Common Stock · 56,168 shares Expires 2029-02-11 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F8 · derivative.exercise_date: This award is fully vested. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:38 UTC |
Xie BingGroup President APAC
|
GrantStock Options · Derivative | 86,594 | $0.00 Strike: $20.44 | $0.00 |
DisclosureSEC source: 0001944048-23-000066 · wk-form4_1693003089.xml · derivative · entry 10 Xie Bing · CIK 0001967716 · Group President APAC 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,594 Underlying: Common Stock · 86,594 shares Expires 2030-02-10 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F8 · derivative.exercise_date: This award is fully vested. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:38 UTC |
Xie BingGroup President APAC
|
GrantStock Options · Derivative | 98,988 | $0.00 Strike: $22.23 | $0.00 |
DisclosureSEC source: 0001944048-23-000066 · wk-form4_1693003089.xml · derivative · entry 9 Xie Bing · CIK 0001967716 · Group President APAC 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 98,988 Underlying: Common Stock · 98,988 shares Expires 2031-02-08 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F4 · derivative.exercise_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:38 UTC |
Xie BingGroup President APAC
|
GrantStock Options · Derivative | 113,797 | $0.00 Strike: $22.40 | $0.00 |
DisclosureSEC source: 0001944048-23-000066 · wk-form4_1693003089.xml · derivative · entry 8 Xie Bing · CIK 0001967716 · Group President APAC 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,797 Underlying: Common Stock · 113,797 shares Expires 2032-02-14 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F3 · derivative.exercise_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:38 UTC |
Xie BingGroup President APAC
|
GrantStock Options · Derivative | 102,484 | $0.00 Strike: $21.97 | $0.00 |
DisclosureSEC source: 0001944048-23-000066 · wk-form4_1693003089.xml · derivative · entry 7 Xie Bing · CIK 0001967716 · Group President APAC 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,484 Underlying: Common Stock · 102,484 shares Expires 2033-02-13 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F2 · derivative.exercise_date: This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:38 UTC |
Xie BingGroup President APAC
|
GrantRestricted Stock Units · Derivative | 28,781 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000066 · wk-form4_1693003089.xml · derivative · entry 6 Xie Bing · CIK 0001967716 · Group President APAC 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,781 Underlying: Common Stock · 28,781 shares Expires not disclosed F5 · security: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F5 · derivative.exercise_price: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F4 · derivative.exercise_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. F4 · derivative.expiration_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:38 UTC |
Xie BingGroup President APAC
|
GrantRestricted Stock Units · Derivative | 28,803 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000066 · wk-form4_1693003089.xml · derivative · entry 5 Xie Bing · CIK 0001967716 · Group President APAC 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,803 Underlying: Common Stock · 28,803 shares Expires not disclosed F5 · security: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F5 · derivative.exercise_price: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F3 · derivative.exercise_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. F3 · derivative.expiration_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:38 UTC |
Xie BingGroup President APAC
|
GrantRestricted Stock Units · Derivative | 31,885 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000066 · wk-form4_1693003089.xml · derivative · entry 4 Xie Bing · CIK 0001967716 · Group President APAC 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,885 Underlying: Common Stock · 31,885 shares Expires not disclosed F5 · security: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F5 · derivative.exercise_price: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F6 · derivative.exercise_date: This award will vest in full on 02/13/2026, subject to the reporting person's continued service through the vesting date. F6 · derivative.expiration_date: This award will vest in full on 02/13/2026, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:38 UTC |
Xie BingGroup President APAC
|
GrantRestricted Stock Units · Derivative | 9,016 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000066 · wk-form4_1693003089.xml · derivative · entry 3 Xie Bing · CIK 0001967716 · Group President APAC 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,016 Underlying: Common Stock · 9,016 shares Expires not disclosed F1 · security: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F1 · derivative.exercise_price: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F4 · derivative.exercise_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. F4 · derivative.expiration_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:38 UTC |
Xie BingGroup President APAC
|
GrantRestricted Stock Units · Derivative | 11,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000066 · wk-form4_1693003089.xml · derivative · entry 2 Xie Bing · CIK 0001967716 · Group President APAC 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,520 Underlying: Common Stock · 11,520 shares Expires not disclosed F1 · security: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F1 · derivative.exercise_price: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F3 · derivative.exercise_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. F3 · derivative.expiration_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:38 UTC |
Xie BingGroup President APAC
|
GrantRestricted Stock Units · Derivative | 12,386 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000066 · wk-form4_1693003089.xml · derivative · entry 1 Xie Bing · CIK 0001967716 · Group President APAC 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,386 Underlying: Common Stock · 12,386 shares Expires not disclosed F1 · security: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F1 · derivative.exercise_price: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F2 · derivative.exercise_date: This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date. F2 · derivative.expiration_date: This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:35 UTC |
Wolk Joseph JDirector
|
GrantDeferred Share Units · Derivative | 7,620 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000064 · wk-form4_1693002935.xml · derivative · entry 2 Wolk Joseph J · CIK 0001744564 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,620 Underlying: Common Stock · 7,620 shares Expires not disclosed F2 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F2 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F2 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:35 UTC |
Wolk Joseph JDirector
|
OtherCommon Stock | 538 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001944048-23-000064 · wk-form4_1693002935.xml · nonDerivative · entry 1 Wolk Joseph J · CIK 0001744564 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 538 F1 · price: On July 24, 2023, Johnson & Johnson commenced a registered exchange offer to holders of shares of Johnson & Johnson common stock to exchange Johnson & Johnson common stock for Kenvue Inc. ("Kenvue") common stock. The final exchange ratio was 8.0324 shares of Kenvue common stock per share of Johnson & Johnson common stock accepted in the exchange offer. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:32 UTC |
WIDMER KATHYGroup President LATAM
|
GrantStock Options · Derivative | 41,271 | $0.00 Strike: $15.62 | $0.00 |
DisclosureSEC source: 0001944048-23-000062 · wk-form4_1693002714.xml · derivative · entry 13 WIDMER KATHY · CIK 0001482594 · Group President LATAM 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,271 Underlying: Common Stock · 41,271 shares Expires 2027-02-13 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F8 · derivative.exercise_date: This award is fully vested. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:32 UTC |
WIDMER KATHYGroup President LATAM
|
GrantStock Options · Derivative | 59,176 | $0.00 Strike: $17.49 | $0.00 |
DisclosureSEC source: 0001944048-23-000062 · wk-form4_1693002714.xml · derivative · entry 12 WIDMER KATHY · CIK 0001482594 · Group President LATAM 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,176 Underlying: Common Stock · 59,176 shares Expires 2028-02-12 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F8 · derivative.exercise_date: This award is fully vested. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:32 UTC |
WIDMER KATHYGroup President LATAM
|
GrantStock Options · Derivative | 73,229 | $0.00 Strike: $17.82 | $0.00 |
DisclosureSEC source: 0001944048-23-000062 · wk-form4_1693002714.xml · derivative · entry 11 WIDMER KATHY · CIK 0001482594 · Group President LATAM 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,229 Underlying: Common Stock · 73,229 shares Expires 2029-02-11 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F8 · derivative.exercise_date: This award is fully vested. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:32 UTC |
WIDMER KATHYGroup President LATAM
|
GrantStock Options · Derivative | 152,186 | $0.00 Strike: $20.44 | $0.00 |
DisclosureSEC source: 0001944048-23-000062 · wk-form4_1693002714.xml · derivative · entry 10 WIDMER KATHY · CIK 0001482594 · Group President LATAM 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 152,186 Underlying: Common Stock · 152,186 shares Expires 2030-02-10 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F8 · derivative.exercise_date: This award is fully vested. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:32 UTC |
WIDMER KATHYGroup President LATAM
|
GrantStock Options · Derivative | 132,117 | $0.00 Strike: $22.23 | $0.00 |
DisclosureSEC source: 0001944048-23-000062 · wk-form4_1693002714.xml · derivative · entry 9 WIDMER KATHY · CIK 0001482594 · Group President LATAM 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132,117 Underlying: Common Stock · 132,117 shares Expires 2031-02-08 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F4 · derivative.exercise_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:32 UTC |
WIDMER KATHYGroup President LATAM
|
GrantStock Options · Derivative | 129,813 | $0.00 Strike: $22.40 | $0.00 |
DisclosureSEC source: 0001944048-23-000062 · wk-form4_1693002714.xml · derivative · entry 8 WIDMER KATHY · CIK 0001482594 · Group President LATAM 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129,813 Underlying: Common Stock · 129,813 shares Expires 2032-02-14 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F3 · derivative.exercise_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.